Drug Discovery, Design, Development, and Delivery > Nova Content
Moderna recently registered a significant triumph in its ongoing patent dispute concerning its Covid-19 vaccine against Pfizer and... Read More »
As the relentless march of time continues, pharmaceutical executives find themselves facing the inevitability of patent expirations and... Read More »
BeiGene, a biotechnology company, has taken legal action by filing patent infringement lawsuits against pharmaceutical companies Sandoz... Read More »
Shares of UroGen Pharma (NASDAQ: URGN) took a minor premarket hit following news that Teva Pharmaceutical (NYSE: TEVA) has submitted an... Read More »
Corcept Therapeutics experienced a significant drop in its stock value by 27% on Tuesday following an unfavorable verdict... Read More »
Source: https://www.greyb.com/blog/drug-patents-expiring-2024/
The pharmaceutical industry is undergoing a... Read More »
In a groundbreaking legal development, Eli Lilly has secured a remarkable victory in a high-stakes patent... Read More »
When it comes to generic medications, the Abbreviated New Drug Application (ANDA) process plays a crucial... Read More »
When it comes to preparing an Abbreviated New Drug Application (ANDA), there are several common pitfalls that applicants often encounter... Read More »
The Abbreviated New Drug Application (ANDA) process plays a vital role in the pharmaceutical industry, enabling generic drug manufacturers ... Read More »
The Hatch-Waxman Act, officially known as the Drug Price Competition and Patent Term Restoration Act, revolutionized the pharmaceutical... Read More »
Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought battle ... Read More »
Two days ago, the companies that joined forces in order to develop the first Covid vaccine that got approval for emergency use by FDA... Read More »
Less than two months ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent... Read More »
This morning we released our third annual ANDA Litigation Intelligence Report. The report covers high-level statistics related to Hatch-Waxman... Read More »
In early 1983, Bolar Pharmaceutical Inc. wanted to bring a generic version of the Dalmane drug, a sleeping pill, to the market. At that... Read More »
Two weeks ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent infringement alleging... Read More »
Last week, a bipartisan group of six U.S. senators sent a letter to USPTO asking to take measures in order to combat patent thickets... Read More »
Global health care spending is predicted to reach $10 trillion USD during 2022 with almost 30% of it belonging to the USA. It might sound... Read More »
A couple of weeks ago we released our second annual ANDA Litigation Intelligence Report where we covered the rankings, statistics, and comprehensive analysis of... Read More »
Comments
vagisha singhNice points mention in this post and it was very usefull post ,thanks for post
Sep 4, 2021
vagisha singhit is nice and usefull post .thank you for post
Sep 4, 2021